Results 121 to 130 of about 1,925 (192)

Knowledge, attitudes, and practices of pediatricians in Crete, Greece, regarding RSV immunization: a cross-sectional study. [PDF]

Eur J Pediatr
Vrentzos D, Pavlopoulou I, Syrogiannopoulos GA, Grivea I, Ladomenou F.   +4 more
europepmc   +1 more source

Meta-analysis of the efficacy of palivizumab versus nirsevimab at preventing medically attended respiratory syncytial virus infections in non-hospitalized preterm infants. [PDF]

Hum Vaccin Immunother
Fullarton J, Paes B, Waghorne N, Keary I, Rodgers-Gray B, Carbonell-Estrany X.   +5 more
europepmc   +1 more source

Comparative Analysis of Reported Adverse Events with Nirsevimab and Palivizumab: A FAERS Observational Study. [PDF]

Kans J Med
Touffaha I, Ablah E, Okut H, Homan G.
europepmc   +1 more source

Nirsevimab and a Community Recall-Based Immunization Strategy for Child Bronchiolitis Prevention.

JAMA Netw Open
Boracchini R, Canova B, Cesarini M, De Marchi I, Brigadoi G, Barbieri E, Donà D, Giaquinto C, Baraldi E, Cantarutti A.   +9 more
europepmc   +1 more source

Impact of Nirsevimab on Pediatric RSV-Related Lower Respiratory Tract Infections: A Retrospective Pre-Post Observational Study in Tuscany, Italy. [PDF]

Infect Dis Ther
Nieddu F, Verzieri M, Vignoli M, Astorino V, Boscia S, Pisano L, Ricci S, Lodi L, Guarnieri V, Di Berardino F, Figlioli F, Masi S, Indolfi G, Azzari C, Moriondo M.   +14 more
europepmc   +1 more source

Estimation of Public Health Impact with Use of Nirsevimab During the 2024-2025 RSV Season in the USA: a Modeling Study. [PDF]

Pulm Ther
Yarnoff B, Neary MP, Gabriel V, Ghemmouri M, Hodges EN, Tribaldos M, Geurtsen J, Chit A, Beuvelet M, Soudani S, Musci R, Krilov LR.   +11 more
europepmc   +1 more source

Impact of Nirsevimab on bronchiolities in pediatric primary care in Lazio Region: an observational study. [PDF]

Ital J Pediatr
Petrone D, Sani I, De Vittori V, Brenna S, Rotili PL, Fonte MT, Scientific Committee of the Italian Pediatrician Federation (FIMP), Rome, Italy.   +8 more
europepmc   +1 more source

Dual Immunization Against RSV With RSVpreF and Nirsevimab.

JAMA Pediatr
Tréluyer L, Bertrand M, Gabet A, Jabagi MJ, Kolla E, Olié V, Zureik M, Rachas A.   +7 more
europepmc   +1 more source

Nirsevimab effectiveness, number needed to immunize and impact on severe RSV outcomes, a test-negative study in Quebec, Canada. [PDF]

Lancet Reg Health Am
Carazo S, Ouakki M, Skowronski DM, Paquette M, Brousseau N, Talbot D, Guay CA, Quach C, Gilca R, Papenburg J.   +9 more
europepmc   +1 more source